{"id":"valproid-acid-plus-corticosteroids","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Weight gain"},{"rate":"5-10%","effect":"Hirsutism"},{"rate":"5-10%","effect":"Acne"},{"rate":"1-5%","effect":"Liver enzyme elevation"},{"rate":"1-5%","effect":"Thrombocytopenia"},{"rate":"1-5%","effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL780","moleculeType":"Small molecule","molecularWeight":"393.35"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Valproic acid is thought to exert its effects by inhibiting the reuptake of certain neurotransmitters, such as serotonin and dopamine, and by reducing the release of excitatory neurotransmitters. Corticosteroids, on the other hand, work by suppressing the immune system's response to inflammation, thereby reducing the production of pro-inflammatory cytokines and mediators.","oneSentence":"Valproic acid is a mood stabilizer that works by reducing the activity of certain brain chemicals, while corticosteroids are anti-inflammatory agents that reduce swelling and inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:52:39.202Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seizure prevention, Migraine prophylaxis, Inflammatory conditions such as asthma and rheumatoid arthritis"}]},"trialDetails":[{"nctId":"NCT00681980","phase":"PHASE3","title":"Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2008-02","conditions":"Paraparesis Spastic Tropical","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"valproid acid plus corticosteroids","genericName":"valproid acid plus corticosteroids","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Valproic acid is a mood stabilizer that works by reducing the activity of certain brain chemicals, while corticosteroids are anti-inflammatory agents that reduce swelling and inflammation. Used for Seizure prevention, Migraine prophylaxis, Inflammatory conditions such as asthma and rheumatoid arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}